Neumora Therapeutics Inc. Common Stock (NMRA) Revenue Analysis | Historical Sales Growth & Trends - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Neumora Therapeutics Inc....

    NASDAQ: NMRA · Real-Time Price · USD
    1.68
    0.05 (3.07%)
    At close: Sep 05, 2025, 3:59 PM
    1.68
    0.00%
    After-hours: Sep 05, 2025, 05:10 PM EDT

    Neumora Therapeutics Common Stock Revenue

    Neumora Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending June 30, 2025, Neumora Therapeutics Common Stock generated $0 in revenue.
    Revenue (ttm)
    0
    Revenue Growth
    n/a
    Price / Sales Ratio
    0
    Revenue / Employee
    0
    Employees
    110
    Market Cap
    272.07M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Dec 31, 2024 0 n/a
    Dec 31, 2023 0 n/a
    Dec 31, 2022 0 n/a
    Dec 31, 2021 0 n/a
    Dec 31, 2020 0 n/a
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist